Multiple endocrine neoplasia type 2 differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 13: | Line 13: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |[[Medullary thyroid carcinoma]] | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |[[Medullary thyroid carcinoma]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[Medullary thyroid cancer]] (MTC) is a form of [[thyroid carcinoma]] which originates from the [[parafollicular cell]]s (C | | style="padding: 5px 5px; background: #F5F5F5;" |[[Medullary thyroid cancer]] (MTC) is a form of [[thyroid carcinoma]] which originates from the [[parafollicular cell]]s ([[C cell]]s), which produce the [[hormone]] [[calcitonin]]. | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |[[C-cell hyperplasia]] | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |[[C-cell hyperplasia]] |
Revision as of 16:31, 28 September 2015
Multiple endocrine neoplasia type 2 Microchapters |
Differentiating Multiple endocrine neoplasia type 2 from other Diseases |
---|
Diagnosis |
Treatment |
Multiple endocrine neoplasia type 2 differential diagnosis On the Web |
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 2 differential diagnosis |
FDA on Multiple endocrine neoplasia type 2 differential diagnosis |
CDC on Multiple endocrine neoplasia type 2 differential diagnosis |
Multiple endocrine neoplasia type 2 differential diagnosis in the news |
Blogs on Multiple endocrine neoplasia type 2 differential diagnosis |
Directions to Hospitals Treating Multiple endocrine neoplasia type 2 |
Risk calculators and risk factors for Multiple endocrine neoplasia type 2 differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Multiple endocrine neoplasia type 2 must be differentiated from medullary thyroid carcinoma, C-cell hyperplasia, pheochromocytoma, von Hippel Lindau syndrome, hereditary paraganglioma-pheochromocytoma, polycythemia and paraganglioma/pheochromocytoma syndrome, neurofibromatosis type 1 and multiple endocrine neoplasia type 1 (MEN 1).
Differential Diagnosis
Multiple endocrine neoplasia type 2 must be differentiated from following hereditary diseases.